Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Evogene, Tel Aviv University Launch AI Drug Discovery Initiative

Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial

Cyllene Raises €33m to Advance Neurogenic Bladder DNA Medicine

Anifrolumab Phase III trial meets primary endpoint in systemic lupus erythematosus

Read more

AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program

Read more

Esperion’s Bempedoic Acid/ Ezetimibe Tablet Achieves Positive Phase II Results

Read more

La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA (angiotensin II)

Read more

PCI Strengthens Position in Europe with Investment in Ireland

Read more

Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies

Read more

HiFiBiO Therapeutics closes £55m Series C financing

Read more

Fasenra granted US Orphan Drug Designation for eosinophilic oesophagitis

Read more

New Technologies for HPAPI Manufacturing and Containment

Read more

Lannett Enters Into Distribution Agreement For Posaconazole Delayed-Release Tablets; Launch To Commence Shortly

Read more

Posts pagination

Previous Page 1 of 938 … Page 587 of 938 … Page 938 of 938 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version